26 April 2025: The Annual General Meeting of Aker BioMarine ASA was held
yesterday as a digital meeting with online participation. All proposals on the
agenda were adopted. The complete minutes are attached to this release.

For further information, please contact 
Christopher Robin Vinter, VP Strategic Finance & IR 
Mobile: +47 911 60 820 
Email: Christopher.vinter@akerbiomarine.com 

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act. About Aker BioMarine Aker BioMarine
is a leading human health and nutrition innovator that develops krill-derived
products for consumer health and nutrition. Krill is a natural, powerful, and
health-promoting source of nutrients from the pristine waters of Antarctica, and
Aker BioMarine has a unique position in its industry. The ingredient portfolio
consists of Superba Krill Oil, Lysoveta, FloraMarine, and PL+, as well as the
consumer brand, Kori Krill. The innovative approach also extends into the
spin-offs AION (reduce and recycle plastic waste across industries) and
Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock
Exchange (AKBM). More information is available at www.akerbiomarine.com.